These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 63273)

  • 1. Conditions favoring immunological enhancement of a murine allogeneic lymphoma.
    Rumi L; Colmerauer ME; Pasqualini CD
    Arch Geschwulstforsch; 1976; 46(6):457-60. PubMed ID: 63273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetics of the graft versus host reaction during allogeneic tumour enhancement.
    Piazzon I; Déroche A; Pasqualini CD
    Arch Geschwulstforsch; 1980; 50(4):322-6. PubMed ID: 7458579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific enhancement of tumor growth and depression of cell-mediated immunity following sensitization to soluble tumor antigens.
    Rao VS; Bonavida B
    Cancer Res; 1976 Apr; 36(4):1384-91. PubMed ID: 56998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody-mediated suppression of grafted lymphoma. III. Evaluation of the role of thymic function, non-thymus-derived lymphocytes, macrophages, platelets, and polymorphonuclear leukocytes in syngeneic and allogeneic hosts.
    Shin HS; Hayden M; Langley S; Kaliss N; Smith MR
    J Immunol; 1975 Apr; 114(4):1255-63. PubMed ID: 1078832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunological stimulation with modified lymphoma cells in a minimally responsive tumor-host system.
    Prager MD; Baechtel FS; Ribble RJ; Ludden CM; Mehta JM
    Cancer Res; 1974 Dec; 34(12):3203-9. PubMed ID: 4429949
    [No Abstract]   [Full Text] [Related]  

  • 6. Antigenic differences between AKR lymphoma and thymus cells leading to detection of a tumor antigen associated with immunological enhancement.
    Laguens RP; Colmerauer ME; Segal A; Pasqualini CD
    Int J Cancer; 1978 Jun; 21(6):779-83. PubMed ID: 78915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effector cell stimulation-inhibition of in vitro lymphoma cell DNA synthesis and correlation with in vivo antitumor response.
    Gordon WC; Prager MD
    Cancer Res; 1977 Feb; 37(2):507-13. PubMed ID: 832275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Active immunological enhancement of sarcoma 180 in splenectomized Swiss mice.
    Dosne Pasqualini C; Colmerauer ME
    Biomedicine; 1976 Jul; 25(6):202-4. PubMed ID: 963183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of syngeneic RNA pretreatment on the growth of an allogeneic mouse tumor.
    Comerauer ME; Dosne Pasqualini C
    Acta Physiol Lat Am; 1976; 26(2):150-3. PubMed ID: 1030178
    [No Abstract]   [Full Text] [Related]  

  • 10. Thymectomy does not affect tumour rejection and cytophilic activity in a murine allogeneic lymphoma model.
    Barrera CN; Mazzolli AB; Colmerauer ME; Pasqualini CD
    Allergol Immunopathol (Madr); 1978; 6(5):403-8. PubMed ID: 217260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-specific antigen of murine T-lymphoma defined with monoclonal antibody.
    Allison JP; McIntyre BW; Bloch D
    J Immunol; 1982 Nov; 129(5):2293-300. PubMed ID: 6181166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of tumors as a result of graft-versus-host reaction.
    Cornelius EA
    Exp Hematol; 1973; 1(3):135-49. PubMed ID: 4153858
    [No Abstract]   [Full Text] [Related]  

  • 13. Detection of soluble tumor-associated antigens in serum of tumor-bearing rats and their immunological role in vivo.
    Srinivasa Rao V; Bonavida B
    Cancer Res; 1977 Sep; 37(9):3385-9. PubMed ID: 884683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunological enhancement of a murine allogeneic lymphoma.
    Pasqualini CD; Colmerauer ME
    Medicina (B Aires); 1976; 36(3):189-92. PubMed ID: 966987
    [No Abstract]   [Full Text] [Related]  

  • 15. Radioresistant inhibition of lymphoma growth in congenitally athymic (nude) mice.
    Campanile F; Crino L; Bonmassar E; Houchens D; Goldin A
    Cancer Res; 1977 Feb; 37(2):394-8. PubMed ID: 832264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endotoxin-stimulated immune response to modified lymphoma cells.
    Prager MD; Ludden CM; Mandy WJ; Allison JP; Kitto GB
    J Natl Cancer Inst; 1975 Mar; 54(3):773-5. PubMed ID: 1168264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Description of a murine B lymphoma tumor-specific antigen.
    Koch S; Zalcberg JR; McKenzie IF
    J Immunol; 1984 Aug; 133(2):1070-7. PubMed ID: 6203965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An investigation into the influence of a graft-versus-host reaction, induced by parent line cells, on the growth of lymphoma transplants in F1 hybrid mice.
    Palmer AM; Symes MO
    Folia Biol (Praha); 1974; 20(1):26-35. PubMed ID: 4154872
    [No Abstract]   [Full Text] [Related]  

  • 19. Morphological study of allogeneic tumor growth in mice bearing a glass cylinder.
    Filippa DA; Dosne Pasqualini C
    Medicina (B Aires); 1975; 35(1):29-36. PubMed ID: 1092950
    [No Abstract]   [Full Text] [Related]  

  • 20. Analysis of murine oncofetal antigens as tumor-associated transplantation antigens.
    Chism SE; Wallis S; Burton RC; Warner NL
    J Immunol; 1976 Nov; 117(5 Pt.2):1870-7. PubMed ID: 993583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.